CD19 isoforms enabling resistance to CART-19 immunotherapy are expressed in B-ALL patients at initial diagnosis J Fischer, C Paret, K El Malki, F Alt, A Wingerter, MA Neu, B Kron, ... Journal of Immunotherapy (Hagerstown, Md.: 1997) 40 (5), 187, 2017 | 222 | 2017 |
Benefits of exercise training for children and adolescents undergoing cancer treatment: results from the randomized controlled MUCKI trial S Stössel, MA Neu, A Wingerter, W Bloch, P Zimmer, C Paret, KE Malki, ... Frontiers in Pediatrics 8, 243, 2020 | 47 | 2020 |
Activation of the basal cell carcinoma pathway in a patient with CNS HGNET-BCOR diagnosis: consequences for personalized targeted therapy C Paret, J Theruvath, A Russo, B Kron, K El Malki, N Lehmann, ... Oncotarget 7 (50), 83378, 2016 | 36 | 2016 |
Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy C Paret, A Russo, H Otto, A Mayer, S Zahnreich, W Wagner, D Samuel, ... Oncotarget 8 (69), 114210, 2017 | 30 | 2017 |
Ceritinib-Induced regression of an insulin-like growth factor-driven neuroepithelial brain tumor A Russo, C Paret, F Alt, J Burhenne, M Fresnais, W Wagner, M Glaser, ... International journal of molecular sciences 20 (17), 4267, 2019 | 22 | 2019 |
IGF1R is a potential new therapeutic target for HGNET-BCOR brain tumor patients N Vewinger, S Huprich, L Seidmann, A Russo, F Alt, H Bender, C Sommer, ... International journal of molecular sciences 20 (12), 3027, 2019 | 21 | 2019 |
Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma A Wingerter, K El Malki, R Sandhoff, L Seidmann, DC Wagner, ... Cancers 13 (3), 520, 2021 | 20 | 2021 |
Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients M Winker, S Stössel, MA Neu, N Lehmann, K El Malki, C Paret, N Joisten, ... Supportive Care in Cancer, 1-4, 2021 | 17 | 2021 |
Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma O Beck, C Paret, A Russo, J Burhenne, M Fresnais, K Steimel, ... Cancers 12 (4), 793, 2020 | 17 | 2020 |
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1 C Paret, N Lehmann, H Bender, M Sprang, CJ Sommer, D Cana, ... Cancers 13 (22), 5838, 2021 | 5 | 2021 |
Tumor lipids of pediatric papillary renal cell carcinoma stimulate unconventional T cells N Lehmann, C Paret, K El Malki, A Russo, MA Neu, A Wingerter, ... Frontiers in immunology 11, 1819, 2020 | 5 | 2020 |
EPEN-29. INDIVIDUALIZED THERAPY OF AN ANAPLASTIC EPENDYMOMA PEDIATRIC PATIENT WITH A NOTCH1 GERMLINE MUTATION A Russo, C Paret, N Lehmann, H Bender, A Wingerter, MA Neu, F Alt, ... Neuro-oncology 20 (Suppl 2), i79, 2018 | 1 | 2018 |
Targeting H3K27 Mutant Diffuse Midline Glioma Via Glucosylceramide Synthase Inhibitors C Paret, R Sandhoff, K ElMalki, A Wingerter, S Zahnreich, K Frauenknecht, ... PEDIATRIC BLOOD & CANCER 68, S115-S115, 2021 | | 2021 |
Frequency of Hereditary Cancer Syndroms in Children-A Single Institution Experience F Alt, M Neu, C Paret, N Lehmann, K El Malki, O Beck, J Faber, A Russo PEDIATRIC BLOOD & CANCER 68, S540-S540, 2021 | | 2021 |
HIGH GRADE GLIOMAS C Paret, R Sandhoff, K El Malki, KBM Frauenknecht, A Wingerter, ... NEURO-ONCOLOGY, 2021 | | 2021 |
HGG-03. THE GLYCOSPHINGOLIPIDS METABOLISM IS A NOVEL TARGET IN H3K27M-MUTANT DIFFUSE MIDLINE GLIOMA C Paret, R Sandhoff, K El Malki, KBM Frauenknecht, A Wingerter, ... Neuro-Oncology 23 (Suppl 1), i17, 2021 | | 2021 |
16P How to translate what we learned from Gaucher’s disease into new treatments for brain tumours C Paret, R Sandhoff, K El Malki, K Frauenknecht, A Wingerter, N Vewinger, ... Annals of Oncology 32, S7, 2021 | | 2021 |
Translation of Physical Activity Research into Practice: An Example in Paediatric Oncology S Stoessel, MA Neu, A Wingerter, A Russo, K ElMalki, N Henninger, ... PEDIATRIC BLOOD & CANCER 67, S375-S376, 2020 | | 2020 |
16P Molecular analysis for precision oncology of children: Beyond genomics C Paret, W Arthur, L Seidmann, N Lehmann, N Vewinger, L Roth, ... Annals of Oncology 31, S1222, 2020 | | 2020 |
Benefits On Cancer-related Fatigue In Children After Exercise Training: Results From The Randomized, Controlled Mucki-trial S Stoessel, MA Neu, A Wingerter, W Bloch, P Zimmer, C Paret, ... Med. Sci. Sports Exerc. 52 (17), 808-809, 2020 | | 2020 |